Literature DB >> 34292404

Solid-phase synthesis and evaluation of linear and cyclic ferrocenoyl/ruthenocenoyl water-soluble hexapeptides as potential antibacterial compounds.

Johana Gómez1, Diego Sierra2, Claudia Ojeda3, Sugina Thavalingam4, Reece Miller4, Fanny Guzmán5, Nils Metzler-Nolte4.   

Abstract

A series of novel water-soluble short peptide-bioconjugates containing a ferrocenoyl (Fc) or ruthenocenoyl (Rc) unit was synthesized and characterized to combine the unique activity of ferrocene and the isoelectronic ruthenocene with precisely designed peptide structures. We aim at evaluating these bioconjugates as a new class of OrganoMetallic Short AntiMicrobial Peptides (OM-SAMPs). The series of OM-SAMPs was designed with a set of linear and "head-to-tail" cyclic metallocene-based hexapeptides derived from the homo-sequence H-KKKKKK-NH2 by substitution of lysine (K) by tryptophan (W) and by orthogonal derivatization of the ε-N-amine group of lysine by a metallocene moiety. Peptide conjugates were characterized by RP-HPLC, mass spectrometry (ESI and MALDI-TOF) and circular dichroism (CD) spectroscopy. Gram-positive and Gram-negative antibacterial activity testings were carried out to explore the role of insertion of the metallocene fragment into the peptide, and the effect of the modification of the cationic charge and aromatic residues on the physiochemical properties of these OM-SAMPs. These results show that the insertion of two tryptophan residues and ferrocenoyl/ruthenocenoyl moieties into a linear homo-sequence peptides increase significantly their antibacterial activity with minimum inhibitory concentration values as low as 5 μM for the most active compounds. However, "head-to-tail" cyclic metallocene-based hexapeptides were not active against Gram-negative bacteria up to concentrations of 50 μM. These studies provide a better understanding of the role of structural modifications to enhance antibacterial peptide activity, which is promising for their therapeutic application.
© 2021. Society for Biological Inorganic Chemistry (SBIC).

Entities:  

Keywords:  Antimicrobial peptides; Ferrocene; Minimum inhibitory concentration; Organometallic peptides; Peptide bioconjugates; Ruthenocene

Year:  2021        PMID: 34292404     DOI: 10.1007/s00775-021-01877-5

Source DB:  PubMed          Journal:  J Biol Inorg Chem        ISSN: 0949-8257            Impact factor:   3.358


  33 in total

1.  The pharmacophore of short cationic antibacterial peptides.

Authors:  Morten B Strøm; Bengt Erik Haug; Merete L Skar; Wenche Stensen; Trine Stiberg; John S Svendsen
Journal:  J Med Chem       Date:  2003-04-24       Impact factor: 7.446

2.  Structure-Activity Relationship-based Optimization of Small Temporin-SHf Analogs with Potent Antibacterial Activity.

Authors:  Sonia André; Shannon K Washington; Emily Darby; Marvin M Vega; Ari D Filip; Nathaniel S Ash; Katy A Muzikar; Christophe Piesse; Thierry Foulon; Daniel J O'Leary; Ali Ladram
Journal:  ACS Chem Biol       Date:  2015-07-30       Impact factor: 5.100

3.  Small cationic antimicrobial peptides delocalize peripheral membrane proteins.

Authors:  Michaela Wenzel; Alina Iulia Chiriac; Andreas Otto; Dagmar Zweytick; Caroline May; Catherine Schumacher; Ronald Gust; H Bauke Albada; Maya Penkova; Ute Krämer; Ralf Erdmann; Nils Metzler-Nolte; Suzana K Straus; Erhard Bremer; Dörte Becher; Heike Brötz-Oesterhelt; Hans-Georg Sahl; Julia Elisabeth Bandow
Journal:  Proc Natl Acad Sci U S A       Date:  2014-03-24       Impact factor: 11.205

Review 4.  Short AntiMicrobial Peptides (SAMPs) as a class of extraordinary promising therapeutic agents.

Authors:  Suhas Ramesh; Thavendran Govender; Hendrik G Kruger; Beatriz G de la Torre; Fernando Albericio
Journal:  J Pept Sci       Date:  2016-07       Impact factor: 1.905

Review 5.  The value of antimicrobial peptides in the age of resistance.

Authors:  Maria Magana; Muthuirulan Pushpanathan; Ana L Santos; Leon Leanse; Michael Fernandez; Anastasios Ioannidis; Marc A Giulianotti; Yiorgos Apidianakis; Steven Bradfute; Andrew L Ferguson; Artem Cherkasov; Mohamed N Seleem; Clemencia Pinilla; Cesar de la Fuente-Nunez; Themis Lazaridis; Tianhong Dai; Richard A Houghten; Robert E W Hancock; George P Tegos
Journal:  Lancet Infect Dis       Date:  2020-07-09       Impact factor: 25.071

6.  Length effects in antimicrobial peptides of the (RW)n series.

Authors:  Zhigang Liu; Anna Brady; Anne Young; Brian Rasimick; Kang Chen; Chunhui Zhou; Neville R Kallenbach
Journal:  Antimicrob Agents Chemother       Date:  2006-12-04       Impact factor: 5.191

7.  Understanding the antimicrobial properties/activity of an 11-residue Lys homopeptide by alanine and proline scan.

Authors:  P Carvajal-Rondanelli; M Aróstica; C A Álvarez; C Ojeda; F Albericio; L F Aguilar; S H Marshall; F Guzmán
Journal:  Amino Acids       Date:  2018-02-21       Impact factor: 3.520

8.  Effect of repetitive lysine-tryptophan motifs on the bactericidal activity of antimicrobial peptides.

Authors:  Ramamourthy Gopal; Chang Ho Seo; Peter I Song; Yoonkyung Park
Journal:  Amino Acids       Date:  2012-08-23       Impact factor: 3.520

9.  Inhibitory effect of short cationic homopeptides against gram-positive bacteria.

Authors:  Fanny Guzmán; Sergio Marshall; Claudia Ojeda; Fernando Albericio; Patricio Carvajal-Rondanelli
Journal:  J Pept Sci       Date:  2013-10-31       Impact factor: 1.905

Review 10.  Design and Application of Antimicrobial Peptide Conjugates.

Authors:  Andre Reinhardt; Ines Neundorf
Journal:  Int J Mol Sci       Date:  2016-05-11       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.